BSLK
Bolt Projects Holdings, Inc.1.8100
-0.0130-0.71%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
7.90MP/E (TTM)
0.06Basic EPS (TTM)
29.82Dividend Yield
0%Recent Filings
8-K
Q3 revenue explodes 7,000%
Bolt Projects Holdings reported preliminary Q3 2025 revenue of approximately $370 thousand, surging 7,000% year-over-year from near-zero base, while gross margins climbed to at least 15% from 5% in Q2, thanks to manufacturing tweaks. The company reaffirmed full-year 2025 revenue guidance at $4.5 million, up 228% from 2024, and boosted gross profit outlook to $1.0 million—a 100% jump from prior estimates—while tapping a $20 million equity line and $30 million convertible debt for liquidity. Yet, ongoing net losses and cash burn raise going-concern doubts.
8-K
Bylaws amended for governance
Bolt Projects Holdings amended its bylaws on October 17, 2025, slashing the stockholder meeting quorum to one-third of voting power while tightening rules on nominations and proxy solicitations to align with SEC universal proxy requirements. These changes streamline governance, clarifying director vacancies and meeting procedures amid modernizing updates. Proxy cards now reserve white for the board only. No financial impacts disclosed.
8-K
Bolt secures $20M equity line
Bolt Projects Holdings inked an equity line of credit deal on September 12, 2025, with Ascent Partners Fund, unlocking up to $20 million in common stock sales at its discretion over 36 months, priced at 96% of recent VWAP with a $1.00 floor. As commitment bait, it issued 85,588 shares upfront, earmarking proceeds for working capital while barring rival equity lines. This flexible cash lifeline bolsters liquidity amid market flux. Yet dilution looms large for shareholders.
8-K
Stockholders approve directors, issuances
Bolt Projects Holdings stockholders overwhelmingly elected Daniel Widmaier, David Breslauer, and Jeri Finard as Class I directors at the August 29, 2025 annual meeting, securing board continuity through 2028. They ratified Elliott Davis as auditors for 2025 and greenlit share issuances under Nasdaq rules for deals with Southern Point Capital and Ascent Partners Fund, enabling flexible capital access. Votes sailed through with minimal opposition. Yet dilution looms from potential new shares.
8-K
Bolt closes $4.25M equity raise
Bolt Projects Holdings closed a $4.25 million private placement on August 15, 2025, issuing 913,979 shares at $4.65 each or pre-funded warrants, exempt from registration under Section 4(a)(2). Rodman & Renshaw served as placement agent, bolstering working capital amid Nasdaq listing pressures. Yet dilution looms large for shareholders. The company must file a resale registration within 10 days.
IPO
Website
Employees
Sector
Industry
BCPC
Balchem Corporation
157.10-1.61
BGLC
BioNexus Gene Lab Corp
4.12-0.02
BIOE
Bio Essence Corp.
0.05+0.00
BIOF
Blue Biofuels Inc.
0.17-0.01
BKTH
Breakthrough Chemistry Inc.
0.17+0.00
BLGO
BioLargo, Inc.
0.18+0.00
BON
Bon Natural Life Limited
1.79+0.04
KBLB
Kraig Biocraft Laboratories, In
0.09+0.00
LOOP
Loop Industries, Inc.
0.92-0.04
OWPC
One World Products Inc.
0.03+0.01